PharmGKB: A worldwide resource for pharmacogenomic information.

about

PharmGKB: A worldwide resource for pharmacogenomic information.

Item

http://www.wikidata.org/entity/Q55442102

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

PharmGKB: A worldwide resource for pharmacogenomic information.

@en

PharmGKB: A worldwide resource for pharmacogenomic information.

@nl

type

Item

label

PharmGKB: A worldwide resource for pharmacogenomic information.

@en

PharmGKB: A worldwide resource for pharmacogenomic information.

@nl

prefLabel

PharmGKB: A worldwide resource for pharmacogenomic information.

@en

PharmGKB: A worldwide resource for pharmacogenomic information.

@nl

P1476

PharmGKB: A worldwide resource for pharmacogenomic information.

@en

P2093

Julia M Barbarino

http://www.w3.org/2001/XMLSchema#string

Michelle Whirl-Carrillo

http://www.w3.org/2001/XMLSchema#string

Teri E Klein

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivatives

P2860

Chapter 7: Pharmacogenomics

Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing: 2014 update

Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process.

Very important pharmacogene summary: thiopurine S-methyltransferase

From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource

CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network

Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing

Pharmacogenomics in the clinic

Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire

Immune self-reactivity triggered by drug-modified HLA-peptide repertoire

P304

e1417

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1002/WSBM.1417

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Russ Altman

P577

2018-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2018-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29474005

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics

pharmacogenetics

P932

6002921

http://www.w3.org/2001/XMLSchema#string